Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks
AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.
22 October 2024
Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals
Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?
15 October 2024
How VigiFlow is helping to keep the wheel of pharmacovigilance turning in South Africa
South Africa’s pharmacovigilance system has been evolving for over a decade with UMC’s data management system supporting them every step of the way.
02 September 2024
To genotype or not to genotype, that is the question
Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and when is genetic testing necessary to avoid the risk of potential side effects?
21 August 2024